Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis
Smith, M.D.; Gibson, R.A.; Brooks, P.M.
Journal of Rheumatology 12(2): 299-305
1985
ISSN/ISBN: 0315-162X PMID: 4032403 Document Number: 255791
Intestinal permeability was measured using a low molecular weight polyethylene glycol as a permeability marker in patients with osteoarthritis, ankylosing spondylitis (AS) and rheumatoid arthritis (RA). Patients with AS showed a significant increase in bowel permeability when compared to controls. Intestinal permeability was also increased in patients with active RA but was less than the control group in RA patients who did not have active joint disease.
Document emailed within 1 workday
Related Documents
Vaile, J.H.; Meddings, J.B.; Yacyshyn, B.R.; Russell, A.S.; Maksymowych, W.P. 1999: Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives Journal of Rheumatology 26(1): 128-135Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542
Manara, M.; Caporali, R.; Favalli, E.G.; Grosso, V.; Atzeni, F.; Sarzi Puttini, P.; Gorla, R.; Bazzani, C.; Fusaro, E.; Pellerito, R.; Rocchetta, P.A.; Sinigaglia, L. 2017: Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry Clinical and Experimental Rheumatology 35(5): 804-809
Fallet, G.H.; Barnes, C.G.; Berry, H.; Mowat, A.G.; Roux, H.; Villiaumey, J. 1987: Coexisting rheumatoid arthritis and ankylosing spondylitis Journal of Rheumatology 14(6): 1135-1138
Rantapää Dahlqvist, S.; Ström, H.; Bjelle, A.; Möller, E. 1985: HLA haplotypes in a family with ankylosing spondylitis and rheumatoid arthritis Journal of Rheumatology 12(3): 518-522
Reis, E.; Carvalho, J. 2013: Onset of rheumatoid arthritis in a patient with ankylosing spondylitis Acta Reumatologica Portuguesa 38(3): 217-219
Cross, M.J.; Smith, E.U.R.; Zochling, J.; March, L.M. 2009: Differences and similarities between ankylosing spondylitis and rheumatoid arthritis: epidemiology Clinical and Experimental Rheumatology 27(4 Suppl 55: S36-S42
McCarey, D.; Sturrock, R.D. 2009: Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis Clinical and Experimental Rheumatology 27(4 Suppl 55: S124-S126
Appel, H.; Loddenkemper, C.; Miossec, P. 2009: Rheumatoid arthritis and ankylosing spondylitis - pathology of acute inflammation Clinical and Experimental Rheumatology 27(4 Suppl 55: S15-S19
Partsch, G.; Tausch, G.; Eberl, R. 1978: Plasma amino acid level in rheumatoid arthritis and ankylosing spondylitis and its variation during age Zeitschrift für Rheumatologie 37(3-4): 105-111
Kiortsis, D.N.; Mavridis, A.K.; Filippatos, T.D.; Vasakos, S.; Nikas, S.N.; Drosos, A.A. 2006: Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis Journal of Rheumatology 33(5): 921-923
Rabinowicz, T.; Jacqueline, F. 1980: Lesions of the nerves of the hip involving chronic rheumatic infections (ankylosing spondylitis, rheumatoid arthritis, arthrosis). Anatomopathologic study Revue du Rhumatisme et des Maladies Osteo-Articulaires 47(1): 37-44
Halla, J.T.; Fallahi, S.; Hardin, J.G. 1983: Nonreducible rotational head tilt and atlantoaxial lateral mass collapse. Clinical and roentgenographic features in patients with juvenile rheumatoid arthritis and ankylosing spondylitis Archives of Internal Medicine 143(3): 471-474
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76
Shi, G.Y. 1990: Juvenile ankylosing spondylitis (JAS) and juvenile rheumatoid arthritis (JRA) Zhonghua Nei Ke Za Zhi 29(12): 710
Wendling, D.; Bidet, A.; Guidet, M. 1990: Intestinal permeability in ankylosing spondylitis Journal of Rheumatology 17(1): 114-115
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Dumbrăveanu, L.; Cuşnir, V.; Groppa, L.; Calinina, L. 2010: HLA B 27 uveitis in ankylosing spondylitis and reactive arthritis Oftalmologia 54(1): 29-35
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Liu, H.C.; Hsieh, K.H. 1986: Abnormal in vitro immunoglobulin synthesis of lymphocytes and increased circulating immune complex in patients with ankylosing spondylitis Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 19(1): 1-6